People: Astellas Pharma Inc (4503.T)
5,830JPY
17 May 2013
¥-20 (-0.34%)
¥5,750
¥5,850
¥5,880
¥5,790
1,573,500
2,001,336
¥6,010
¥3,020
Nogimori, Masafumi
Brief Biography
Mr. Masafumi Nogimori has been serving as Chairman of the Board and Representative Director in Astellas Pharma Inc., since June 20, 2011. His previous titles include Chief Executive Officer, President and Vice President in the Company. He used to work for Fujisawa Pharmaceutical Co., Ltd., and serve as President in another company. He obtained his bachelor's in Medicine from the University of Tokyo in March 1970.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Masafumi Nogimori |
-- |
Yoshihiko Hatanaka |
-- |
Yasuo Ishii |
-- |
Masao Yoshida |
-- |
Yoshiro Miyokawa |
-- |
Yukihiko Sato |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
